ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 173 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,429,000 | +9.1% | 235,611 | +21.2% | 0.01% | 0.0% |
| Q3 2016 | $4,059,000 | -18.6% | 194,380 | -0.6% | 0.01% | -16.7% |
| Q2 2016 | $4,988,000 | +10.8% | 195,560 | +14.9% | 0.01% | 0.0% |
| Q1 2016 | $4,502,000 | -36.0% | 170,198 | +3.6% | 0.01% | -33.3% |
| Q4 2015 | $7,029,000 | +62.3% | 164,304 | +0.6% | 0.01% | +50.0% |
| Q3 2015 | $4,331,000 | -21.3% | 163,354 | -1.0% | 0.01% | -14.3% |
| Q2 2015 | $5,500,000 | +18.9% | 165,005 | +18.7% | 0.01% | +16.7% |
| Q1 2015 | $4,626,000 | -25.4% | 139,003 | -8.3% | 0.01% | -25.0% |
| Q4 2014 | $6,197,000 | +20.0% | 151,639 | -0.5% | 0.01% | +14.3% |
| Q3 2014 | $5,163,000 | -5.6% | 152,384 | -6.1% | 0.01% | 0.0% |
| Q2 2014 | $5,472,000 | +7.0% | 162,330 | +20.4% | 0.01% | 0.0% |
| Q1 2014 | $5,112,000 | +30.7% | 134,847 | +0.7% | 0.01% | +16.7% |
| Q4 2013 | $3,910,000 | -15.5% | 133,899 | -1.1% | 0.01% | -25.0% |
| Q3 2013 | $4,629,000 | +8.8% | 135,343 | +5.0% | 0.01% | 0.0% |
| Q2 2013 | $4,254,000 | – | 128,937 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,045,400 | $21,953,000 | 12.28% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,568,306 | $116,934,000 | 2.16% |
| GREAT POINT PARTNERS LLC | 432,500 | $9,083,000 | 1.80% |
| Consonance Capital Management LP | 619,419 | $13,008,000 | 1.36% |
| RA Capital Management | 489,828 | $10,286,000 | 1.26% |
| Ghost Tree Capital, LLC | 300,000 | $6,300,000 | 1.17% |
| DLD Asset Management, LP | 281,900 | $5,920,000 | 0.95% |
| DLD Asset Management, LP | 281,900 | $5,914,000 | 0.95% |
| Worth Venture Partners, LLC | 36,650 | $770,000 | 0.68% |
| Malaga Cove Capital, LLC | 51,013 | $939,000 | 0.57% |